. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdolescentAdultChildChild, PreschoolClinical ProtocolsGenes, SyntheticGenetic VectorsHumansImmunologic Factors/administration & dosageImmunologic Factors/geneticsImmunologic Factors/therapeutic useIncidenceInfantInformed ConsentInterleukin-2/administration & dosageInterleukin-2/geneticsInterleukin-2/therapeutic useNeoplasm Recurrence, Local/therapyNeuroblastoma/epidemiologyNeuroblastoma/immunologyNeuroblastoma/pathologyNeuroblastoma/therapyRecombinant Fusion Proteins/administration & dosageRecombinant Fusion Proteins/geneticsRecombinant Fusion Proteins/therapeutic useRetroviridae/geneticsSafetySalvage TherapyTransplantation, AutologousTumor Cells, Cultured/transplantationUnited States/epidemiology
Substances: See more » Immunologic FactorsInterleukin-2Recombinant Fusion Proteins
Year: 1992 PMID: 1482707 DOI: 10.1089/hum.1992.3.6-665
Source DB: PubMed Journal: Hum Gene Ther ISSN: 1043-0342 Impact factor: 5.695